Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetals Exploration Regulatory News (MTL)

Share Price Information for Metals Exploration (MTL)

Share Price is delayed by 15 minutes
Get Live Data
13.15    0.00 (0.00%)
Bid:
13.00
Ask:
13.30
Spread: 0.30 (2.308%)
Market Cap: £393.37m
MTL Live PriceLast checked at - London Stock Exchange

Intraday Metals Exploration Share Chart

Form 8.3 - Metals Exploration

27 Jul 2010 16:08

RNS Number : 0152Q
Aerion Fund Management Limited
27 July 2010
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

AERION FUND MANAGEMENT LTD

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

METALS EXPLORATION

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

26 JULY 2010

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES/NO

If YES, specify which:

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

ORD 0.01

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

7,682,919

2.84

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

TOTAL:

7,682,919

2.84

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES/NO

 

 

Date of disclosure:

27th JULY 2010

Contact name:

KEVIN CHOY

Telephone number:

020 7269 4936

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETPGURWMUPUGCM
Date   Source Headline
1st May 20207:00 amRNSQuarterly Update To 31 March 2020
27th Apr 202012:01 pmRNSUpdated Mineral Reserve Estimate
26th Mar 20207:00 amRNSOperational Update
9th Mar 20207:30 amRNSSuspension - Metals Exploration plc
9th Mar 20207:00 amRNSUpdate on Senior Facility & Suspension of Trading
19th Feb 20202:00 pmRNSQuarterly Update to 31 December 2019
31st Jan 20207:00 amRNSSale of Senior Facility Completed
22nd Jan 20207:00 amRNSFunding and Banking Update
15th Nov 20197:00 amRNSQuarterly Update To 30 September 2019
13th Sep 20197:00 amRNSHalf-year Report
8th Aug 20194:20 pmRNSQuarterly Update To 30 June 2019
1st Aug 20197:00 amRNSFunding and Banking Update
28th Jun 20193:11 pmRNSFunding and Banking Update
25th Jun 20196:02 pmRNSResults of AGM
25th Jun 20197:00 amRNSAGM Statement
3rd Jun 20197:00 amRNSFunding and Banking Update
30th May 201910:00 amRNSPosting of Annual Report and Notice of AGM
30th May 20197:06 amRNSFinal Results For The Year Ended 31 December 2018
3rd May 20197:00 amRNSFunding and Banking Update
24th Apr 20197:00 amRNSQuarterly Update To 31 March 2019
12th Apr 20197:00 amRNSAppointment of Nominated Adviser
1st Apr 20197:00 amRNSFunding and Banking Update
29th Mar 20191:25 pmRNSFunding and Banking Update
15th Mar 20197:00 amRNSResignation of Nominated Adviser
12th Mar 201910:15 amRNSFunding & Banking Update-Debt Standstill Requested
7th Mar 201911:00 amRNSPrice Monitoring Extension
7th Mar 20199:05 amRNSSecond Price Monitoring Extn
7th Mar 20199:00 amRNSPrice Monitoring Extension
6th Mar 20193:58 pmRNSFunding and Banking Update
28th Feb 20197:00 amRNSInterim CFO Appointed
27th Feb 20197:00 amRNSResults of Operational Review and Clarifications
18th Feb 201912:35 pmRNSAmendment to Senior Lenders' Facility Agreement
8th Feb 201911:14 amRNSBanking Update - Replacement
8th Feb 201910:08 amRNSBanking Update
5th Feb 201910:51 amRNSAppointment of Non-Executive Director
31st Jan 20194:46 pmRNSBanking Update
30th Jan 20199:23 amRNSQuarterly Update To 31 December 2018
28th Jan 20197:00 amRNSHolding(s) in Company
25th Jan 20193:22 pmRNSDirectorship Change
25th Jan 20199:23 amRNSAppointment of Chairman
24th Jan 201912:09 pmRNSDirectorate Change
16th Jan 20198:36 amRNSCorporate Update
4th Jan 201910:11 amRNSShort Term Loans Update
3rd Jan 20197:14 amRNSAppointment of Darren Bowden as CEO
31st Dec 201810:15 amRNSShort Term Loans Update
6th Dec 201812:07 pmRNSDirectorate Change
22nd Nov 20187:00 amRNSWorking Capital Funding
5th Nov 201812:38 pmRNSBanking Update
2nd Nov 201810:11 amRNSOperations Update
25th Oct 20189:31 amRNSQuarterly Update to 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.